Clinical Trials Logo

Clinical Trial Summary

We propose to undertake a retrospective review of approximately 200 patients with a diagnosis of exudative macular degeneration treated with triple combination therapy (Bevacizumab, Dexamethasone and Photo-dynamic therapy) during the years of 2006 to 2010 at The Retina Center and compare those results with an additional group of approximately 200 patients also treated with triple combination therapy and 20 mg of daily oral zeaxanthin.


Clinical Trial Description

Study parameters will include best corrected visual acuity, number of combination treatments, reduction of central foveal thickness by OCT measurement and development of exudative macular degeneration in the fellow eye. Follow up will include all patients with a minimum of two years. Retrospective review of patient charts in the office of The Retina Center. ;


Study Design

Observational Model: Case Control, Time Perspective: Retrospective


Related Conditions & MeSH terms


NCT number NCT02287298
Study type Observational
Source The Retina Center of St. Louis County, PC
Contact
Status Completed
Phase N/A
Start date August 2014
Completion date December 2015

See also
  Status Clinical Trial Phase
Completed NCT01835067 - Intravitreal tPA and C3F8 for the Treatment of Submacular Haemorrhage as a Complication of Neovascular AMD Phase 2/Phase 3
Completed NCT01674569 - Pilot Study of X-82 in Patients With Wet AMD Phase 1/Phase 2
Recruiting NCT04504123 - MMP-9 Inhibition for Recalcitrant Wet AMD Phase 2
Completed NCT01473251 - Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration N/A
Recruiting NCT05093374 - Treatment of Neovascular AMD: Artificial Intelligence in Real-world Setting Phase 4
Completed NCT01617148 - Wet Macular Degeneration Study to Compare Ranibizumab or Bevacizumab to Aflibercept Phase 4
Completed NCT01535950 - Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD) Phase 2
Active, not recruiting NCT03803631 - CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)